StreetInsider.com News Articles

Neutra Corp subsidiary adds clinical research site in Texas

Mon, 13 Oct 2025 07:09:51 -0500

Neutra Corp (OTC: NTRR) announced that its subsidiary Neutra Life Sciences has added MediNet Family Care Clinic to its clinical research network. The Internal Medicine/Family Medicine site is located near the border of Sugar Land and Houston, Texas.

The facility will support Phase II and III clinical trials focused on chronic conditions including hypertension, diabetes, and hyperlipidemia. The site is operated by a research team with experience in conducting clinical trials.

"This new partnership represents another important step in our long-term strategy to grow organically and provide sponsors and CROs with efficient, responsive, and high-performing research sites," said Sydney Jim, CEO of

Neutra Corp subsidiary adds clinical research site in Texas

Mon, 13 Oct 2025 07:09:51 -0500

Neutra Corp's Subsidiary, Neutra Life Sciences, Adds to Its Site Network With New Joint Venture Partnership in Family Medicine

Mon, 13 Oct 2025 07:09:00 -0500

HOUSTON, TX - October 13, 2025 (NEWMEDIAWIRE) - Neutra Corp (OTC: NTRR) is proud to announce that its wholly owned subsidiary, Neutra Life Sciences, has expanded its clinical research footprint by securing a new clinical trial site, MediNet Family Care Clinic, which specializes in Internal Medicine/Family Medicine. This strategic move aligns with the companys ongoing mission to grow its site management organization (SMO) and bring high-quality, community-based research opportunities to diverse patient populations.

Located in a high-traffic area near the border of Sugar Land and Houston, this Internal Medicine/Family Medicine site is led by an experienced research team with a

Neutra Corp's Subsidiary, Neutra Life Sciences, Adds to Its Site Network With New Joint Venture Partnership in Family Medicine

Mon, 13 Oct 2025 07:09:00 -0500

Located in a high-traffic area near the border of Sugar Land and Houston, this Internal Medicine/Family Medicine site is led by an experienced research team with a

Neutra Corp Launches Corporate Rebranding Initiative, Unveils New Logo, New Website, and Strengthens Focus on Life Sciences Through Its SMO

Mon, 25 Aug 2025 07:39:00 -0500

HOUSTON, TX - August 25, 2025 (NEWMEDIAWIRE) - Neutra Corp (OTC: NTRR) today announced the launch of its corporate rebranding initiative, marked by the unveiling of a new company logo, refreshed brand identity, and redesigned corporate website. This initiative reflects the companys renewed commitment to its life sciences strategy, positioning Neutra Corp firmly within the healthcare sector through its wholly owned subsidiary, Neutra Life Sciences.

The rebrand underscores Neutra Corps transformation from its legacy business ventures toward a clear focus on advancing healthcare innovation. Through Neutra Life Sciences, the company is building a strong foundation in clinical research and site

Neutra Corp Launches Corporate Rebranding Initiative, Unveils New Logo, New Website, and Strengthens Focus on Life Sciences Through Its SMO

Mon, 25 Aug 2025 07:39:00 -0500

Neutra Life Sciences adds joint ventures in podiatry, oncology and dermatology

Mon, 04 Aug 2025 08:39:58 -0500

Neutra Corp (OTC: NTRR) announced its subsidiary Neutra Life Sciences has secured joint venture partnerships with three medical practices across different specialties, according to a company statement.

The partnerships include Epic Foot & Ankle Centers for podiatry services, Aspire Hospital Cancer Centers for radiation oncology, and Radiant Dermatology & Aesthetics Clinic for dermatology services. These sites are entering the onboarding process as part of Neutra Life Sciences' site management organization operations.

The expansion adds to Neutra Life Sciences' multi-specialty platform for clinical research services. The company operates as a site management organization that supports contract research organizations and sponsors conducting clinical trials.

"Our

Neutra Life Sciences adds joint ventures in podiatry, oncology and dermatology

Mon, 04 Aug 2025 08:39:58 -0500

"Our

Neutra Corps Subsidiary, Neutra Life Sciences, Expands Rapidly With New Joint Venture Partnerships

Mon, 04 Aug 2025 08:39:00 -0500

HOUSTON, TX - August 4, 2025 (NEWMEDIAWIRE) - Neutra Corp (OTC: NTRR) is hitting its stride with the purposeful growth in the clinical research industry with Neutra Life Sciences. Since the successful launch of its Site Management Organization (SMO), Neutra Life Sciences has strategically positioned itself for significant growth in the latter part of 2025 and the beginning of 2026. Neutra Life Sciences has solidified its multi-specialty platform by securing another suite of Joint Venture Partnerships.

These new joint venture sites will be in the onboarding process:

Podiatry

Epic Foot & Ankle Centers (www.epicfootandankle.com)

Radiation Oncology

Aspire Hospital

Neutra Corps Subsidiary, Neutra Life Sciences, Expands Rapidly With New Joint Venture Partnerships

Mon, 04 Aug 2025 08:39:00 -0500

These new joint venture sites will be in the onboarding process:

Podiatry

Epic Foot & Ankle Centers (www.epicfootandankle.com)

Radiation Oncology

Aspire Hospital

Neutra Corp subsidiary adds three joint venture partnerships

Mon, 04 Aug 2025 08:30:35 -0500

Neutra Corp (OTC: NTRR) announced that its subsidiary Neutra Life Sciences has secured three new joint venture partnerships to expand its clinical research operations.

The partnerships include Epic Foot & Ankle Centers for podiatry research, Aspire Hospital Cancer Centers for radiation oncology studies, and Radiant Dermatology & Aesthetics Clinic for dermatology trials. These sites are entering the onboarding process, according to the company's statement.

Neutra Life Sciences operates as a Site Management Organization that conducts clinical trials across multiple medical specialties. The company launched this division as part of its expansion into the clinical research industry.

"Our growth reflects the increasing demand for

Neutra Corp subsidiary adds three joint venture partnerships

Mon, 04 Aug 2025 08:30:35 -0500

Neutra Corp (OTC: NTRR) announced that its subsidiary Neutra Life Sciences has secured three new joint venture partnerships to expand its clinical research operations.

"Our growth reflects the increasing demand for

Neutra Corp's Subsidiary, Neutra Life Sciences, Expands Rapidly With New Joint Venture Partnerships

Mon, 04 Aug 2025 08:30:00 -0500

These new joint venture sites will be in the onboarding process:

Podiatry

Epic Foot & Ankle Centers (www.epicfootandankle.com)

Radiation Oncology

Aspire Hospital

Neutra Corp's Subsidiary, Neutra Life Sciences, Expands Rapidly With New Joint Venture Partnerships

Mon, 04 Aug 2025 08:30:00 -0500

These new joint venture sites will be in the onboarding process:

Podiatry

Epic Foot & Ankle Centers (www.epicfootandankle.com)

Radiation Oncology

Aspire Hospital

Neutra Corp Reports Breakthrough First Quarter Following Launch of Its New Clinical Research Network

Mon, 30 Jun 2025 07:39:00 -0500

HOUSTON, TX - June 30, 2025 (NEWMEDIAWIRE) - Neutra Life Sciences, a newly launched Site Management Organization (SMO) and wholly owned subsidiary of Neutra Corp (OTC: NTRR), is proud to announce a strong and promising start to operations in Q1 2025. Founded on the success of a pilot program personally funded by its CEO in 2024, the company has already achieved positive operational cash flow in under six months, signaling a strong market position and operational efficiency from the outset.